Region: Australia

Featured in Special Report 2022 Q2: The Asia IP Elite

30 May 2022

In a setback for Dr Stephen Thaler and team behind the DABUS effort, the most significant win of their global campaign thus far was overturned today

13 April 2022

The tide has turned against rights holders in recent years, write Gavin Adkins and Jacqueline Simpkin of Griffith Hack – though an accompanying trend of expedited trials offers some consolation

21 March 2022

For the first time, country’s top court will hear a case related to patent eligibility for computer-implemented inventions, an area IP owners say is rife with uncertainty

10 March 2022

A recent deal shows that a wider selection of corporates are exploring acquisition opportunities and working with custom R&D labs

08 March 2022

The appellate ruling overturns a recent lower court judgment which exposed life sciences IP plaintiffs to significant additional dangers from health insurer lawsuits

06 January 2022

Beyond China, there was a lot going on in a market that is home to some of the world’s most important patent-producing businesses

21 December 2021

Saturday Opinion: In-house leaders say a mooted patent box regime limited to life sciences will reward companies that get patents already, failing to encourage IP investment in new industries

04 December 2021

The Long Read: Those hoping for clarity on whether AI programmes can be regarded as inventors for patent purposes will be disappointed by the different ways in which courts around the world have handled the issue so far. Helen Macpherson, Tanvi Shah and Avi Toltzis of Baker & McKenzie look at recent developments

20 October 2021

A growing trend in life sciences litigation Down Under has strategic implications for originators and generics/biosimilars alike

28 September 2021